Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 8—August 2024
Research

Phylogeographic Analysis of Mycobacterium kansasii Isolates from Patients with M. kansasii Lung Disease in Industrialized City, Taiwan

Patrick George Tobias Cudahy, Po-Chen Liu, Joshua L. Warren, Benjamin Sobkowiak, Chongguang Yang, Thomas R. Ioerger, Chieh-Yin Wu, Po-Liang Lu, Jann-Yuan Wang, Hsiao-Han Chang, Hung-Ling HuangComments to Author , Ted Cohen, and Hsien-Ho LinComments to Author 
Author affiliations: Yale School of Medicine, New Haven, Connecticut, USA (P.G.T. Cudahy); National Taiwan University, Taipei, Taiwan (P.-C. Liu, C.-Y. Wu, J.-Y. Wang, H.-H. Lin); Yale School of Public Health, New Haven (J.L. Warren, B. Sobkowiak, T. Cohen); Sun Yat-Sen University School of Public Health, Guangzhou, China (C. Yang); Texas A&M University, College Station, Texas, USA (T.R. Ioerger); Kaohsiung Medical University, Kaohsiung, Taiwan (P.-L. Lu, H.-L. Huang); Kaohsiung Medical University Hospital, Kaohsiung, Taiwan (P.-L. Lu, H.-L. Huang); National Tsing Hua University, Hsinchu, Taiwan (H.-H. Chang); Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan (H.-L. Huang)

Main Article

Table

Demographics of included population in study of phylogeographic analysis of Mycobacterium kansasii isolates from patients with M. kansasii lung disease in industrialized city, Taiwan

Characteristic Value
Total no. participants
 216
Mean age, y (SD)
 67.29 (17.59)
Sex
F 70 (32.4)
M
 146 (67.6)
Mean body mass index (SD)
 20.98 (4.14)
Smoking status
Current smoker 46 (21.3)
Ex-smoker 45 (20.8)
Never smoked
 125 (57.9)
Chest radiograph findings
Consolidation 42 (20.1)
Fibrocavitary disease 37 (17.1)
Fibrosis 1 (0.5)
Nodular bronchiectasis 81 (38.8)
Nodule 3 (1.4)
Other† 52 (24.1)
Prior tuberculosis 52 (24.1)
Chronic obstructive disease
 51 (23.6)
Pulmonary disease
Bronchiectasis 35 (16.2)
Asthma 19 (8.8)
Pneumoconiosis 4 (1.9)
Lung cancer 9 (4.2)
Inhaled corticosteroid use
 19 (8.8)
Residential water purification plant‡
Baolai 1 (0.5)
Weng Park 22 (10.2)
Lingkou 4 (1.9)
Lujhu 1 (0.5)
Kaotan 99 (45.8)
Fongshan 70 (32.4)
Chengcinghu 128 (59.3)
Pingding 84 (38.9)

*Values are no. (%) except as indicated. †Other patterns included mixtures of the aforementioned patterns. ‡Participant residences may be supplied by >1 water purification plant.

Main Article

Page created: June 18, 2024
Page updated: July 10, 2024
Page reviewed: July 10, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external